‘Cruel April’ in pharmaceutical industry

The pharmaceutical industry has been messy this April because rebate investigation, FTC’s(Fair Trade Commission) investigation, and tax investigation either was conducted or being conducted now.

First, the pharmaceutical industry has paid sharp attention to the result of prosecution’s rebate investigation on a company.

Since it was observed a number of doctors are involved in the incident and...